145 related articles for article (PubMed ID: 19729056)
21. Radiolabeling of Preformed Niosomes with [
Almasi A; Shahhosseini S; Haeri A; Daha FJ; Geramifar P; Dadashzadeh S
AAPS PharmSciTech; 2018 Nov; 19(8):3859-3870. PubMed ID: 30291544
[TBL] [Abstract][Full Text] [Related]
22. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
Mehta SC; Lai JC; Lu DR
J Microencapsul; 1996; 13(3):269-79. PubMed ID: 8860683
[TBL] [Abstract][Full Text] [Related]
23. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit.
Khattab MA; Farr SJ; Taylor G; Kellaway IW
J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819
[TBL] [Abstract][Full Text] [Related]
24. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
[TBL] [Abstract][Full Text] [Related]
25. A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation.
Kleiter MM; Yu D; Mohammadian LA; Niehaus N; Spasojevic I; Sanders L; Viglianti BL; Yarmolenko PS; Hauck M; Petry NA; Wong TZ; Dewhirst MW; Thrall DE
Clin Cancer Res; 2006 Nov; 12(22):6800-7. PubMed ID: 17121901
[TBL] [Abstract][Full Text] [Related]
26. In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice.
Antimisiaris SG; Klepetsanis P; Zachariou V; Giannopoulou E; Ioannou PV
Int J Pharm; 2005 Jan; 289(1-2):151-8. PubMed ID: 15652207
[TBL] [Abstract][Full Text] [Related]
27. Radiolabeled liposomes as metabolic and scanning tracers in mice. II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles.
Espinola LG; Beaucaire J; Gottschalk A; Caride VJ
J Nucl Med; 1979 May; 20(5):434-40. PubMed ID: 120420
[TBL] [Abstract][Full Text] [Related]
28. A simple and efficient method for radiolabeling of preformed liposomes.
Suresh M; Cao Y
J Pharm Pharm Sci; 1998; 1(1):31-7. PubMed ID: 10942970
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution of liposome/DNA systems after subcutaneous and intraperitoneal inoculation.
Chiaramoni NS; Gasparri J; Speroni L; Taira MC; Alonso Sdel V
J Liposome Res; 2010 Sep; 20(3):191-201. PubMed ID: 19845441
[TBL] [Abstract][Full Text] [Related]
30. Effects of intraperitoneal administration of free and liposome-entrapped doxorubicin on rat peritoneal exudate cell populations.
Storm G; Steerenberg PA; Van Borssum Waalkes M; Crommelin DJ
J Drug Target; 1996; 4(4):255-64. PubMed ID: 9010815
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine.
Arulsudar N; Subramanian N; Mishra P; Sharma RK; Murthy RS
J Drug Target; 2003 Apr; 11(3):187-96. PubMed ID: 13129826
[TBL] [Abstract][Full Text] [Related]
32. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen TM; Mehra T; Hansen C; Chin YC
Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
[TBL] [Abstract][Full Text] [Related]
33. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation.
Chono S; Morimoto K
J Pharm Pharmacol; 2006 Sep; 58(9):1219-25. PubMed ID: 16945180
[TBL] [Abstract][Full Text] [Related]
34. Effects of liposome dose and the presence of lymphosarcoma cells on blood clearance and tissue distribution of large unilamellar liposomes in mice.
Ellens H; Morselt HW; Dontje BH; Kalicharan D; Hulstaert CE; Scherphof GL
Cancer Res; 1983 Jun; 43(6):2927-34. PubMed ID: 6687832
[TBL] [Abstract][Full Text] [Related]
35. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
Allen TM; Everest JM
J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864
[TBL] [Abstract][Full Text] [Related]
36. Mediastinal node and diaphragmatic targeting after intracavitary injection of avidin/99mTc-blue-biotin-liposome system.
Medina LA; Calixto SM; Klipper R; Li Y; Phillips WT; Goins B
J Pharm Sci; 2006 Jan; 95(1):207-24. PubMed ID: 16315246
[TBL] [Abstract][Full Text] [Related]
37. Reduced dose-limiting toxicity of intraperitoneal mitoxantrone chemotherapy using cardiolipin-based anionic liposomes.
Chang RS; Kim J; Lee HY; Han SE; Na J; Kim K; Kwon IC; Kim YB; Oh YK
Nanomedicine; 2010 Dec; 6(6):769-76. PubMed ID: 20570638
[TBL] [Abstract][Full Text] [Related]
38. Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice.
Bally MB; Masin D; Nayar R; Cullis PR; Mayer LD
Cancer Chemother Pharmacol; 1994; 34(2):137-46. PubMed ID: 8194164
[TBL] [Abstract][Full Text] [Related]
39. Studies of the organ distribution in mice of teniposide liposomes designed for treatment of diseases in the mononuclear phagocytic system.
Liliemark E; Liliemark J; Kållberg N; Björkholm M; Sjöström B; Peterson C
Pediatr Res; 1995 Jul; 38(1):7-10. PubMed ID: 7478800
[TBL] [Abstract][Full Text] [Related]
40. A novel approach for the increased delivery of pharmaceutical agents to peritoneum and associated lymph nodes.
Phillips WT; Medina LA; Klipper R; Goins B
J Pharmacol Exp Ther; 2002 Oct; 303(1):11-6. PubMed ID: 12235227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
